Effect of Pitavastatin on restenosis with carotid artery stenting
Not Applicable
- Conditions
- Patients scheduled carotid artery stenting
- Registration Number
- JPRN-UMIN000005501
- Lead Sponsor
- Hiroshima University hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Malignant tumor in active phase 2.Patients who meet contraindication of LIVALO tablet below 1)Patients who have hypersensitivity to LIVALO tablet 2)Patients who have severe liver dysfunction or biliary atresia 3)Patients who are being treated with cyclosporine 4)Pregnant women, women suspected of being pregnant, or lactating women 3.Patients with hypersensitive to contrast media 4.Patients with liver dysfunction [ALT(GPT) 100 IU/L <=] 5.Patients undergoing dialysis 6.Patients with familial hypercholesterolemia 7.Patients who are ineligible in the opinion of the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of carotid artery plaque volume at carotid artery stent region using MDCT
- Secondary Outcome Measures
Name Time Method 1.Max IMT at carotid artery stent region and common carotid artery in ipsilateral side using echo 2.Max IMT at other side of carotid artery stent region using echo 3.The changes in TC, LDL-C, TG, HDL-C, non-HDL-C, LDL-C/HDL-C, RLP-C and MDA-LDL 4.The correlation between change in lipid profiles and change in max IMT at carotid artery stent region and common carotid artery in ipsilateral side 5.The correlation between change in lipid profiles and change in max IMT at other side of carotid artery stent region 6.Change in inflammation marker (CRP, SAA) 7.The correlation between Changes in inflammation marker and change in max IMT at carotid artery stent region and common carotid artery in ipsilateral side 8.The correlation between Changes in inflammation marker and change in max IMT at other side of carotid artery stent region 9.The incidence rate of adverse event 10.The changes in laboratory values